Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,589,505
+$12,835,401 QoQ
Shares Held
635,404
+103.2% QoQ
Ownership
0.499%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#31
of 230 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. RCUS ranks #58 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in RCUS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,589,505 | 635,404 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,754,104 | 312,690 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,327,406 | 139,631 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,412,699 | 471,522 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,322,707 | 408,195 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,342,628 | 298,424 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,184,154 | 146,686 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,074,226 | 135,659 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,601,099 | 105,128 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,970,669 | 263,277 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,159,694 | 113,073 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $757,759 | 42,215 | Shares | Sole | 2023-11-14 | |
| 2022-09-30 | $1,305,148 | 49,891 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $6,488,797 | 160,336 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,386,677 | 68,445 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,782,669 | 137,752 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $951,041 | 33,869 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,301,888 | 204,233 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $10,145,954 | 591,946 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $9,087,447 | 367,318 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $753,281 | 54,271 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||